We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New and Revised Product Specific Guidelines Include Semaglutide, Gabapentin, Albuterol
New and Revised Product Specific Guidelines Include Semaglutide, Gabapentin, Albuterol
The FDA has published 40 new and revised product-specific guidances (PSG) which provide recommendations for developing generic drugs and generating evidence to support ANDA approvals.